Re-imagining Medicinal Chemistry: Leveraging Novel R&D, Advanced Manufacturing to Foster Regional Cluster Growth and Economic Prosperity
Image by Phlow™
Re-imagining Medicinal Chemistry: Leveraging Novel R&D, Advanced Manufacturing to Foster Regional Cluster Growth and Economic Prosperity
“Phlow, along with Civica Rx, AMPAC Fine Chemicals and the Medicines for All Institute, or “M4All,” makeup Virginia’s Gateway Region’s strategic partners who are engaged with progressing this initiative to accelerate the City of Petersburg’s “Advanced Pharmaceutical Manufacturing” campus into a regional cluster.
M4All is based out of Virginia Commonwealth University in the state capital. It is an affiliated research institute of the VCU College of Engineering.
All of VGR’s strategic partners define “essential medicines” as those which satisfy the priority health care needs of the American population to sustain life and conquer disease. Phlow is currently focusing on vulnerable essential medicines in short supply. Together, Phlow and VGR’s other strategic partners involved with the advanced pharma cluster are working on the initiative to keep the ball rolling and are re-imagining the essential medicines supply chain using a method known as “continuous-flow” manufacturing, as well as other advanced manufacturing technologies.”